Cargando…
ACY-1215, a HDAC6 inhibitor, decreases the dexamethasone-induced suppression of osteogenesis in MC3T3-E1 cells
Glucocorticoid-induced osteoporosis is the commonest form of drug-induced osteoporosis. Histone deacetylase 6 (HDAC6) is involved in the differentiation from mesenchymal stem cells to osteoblasts. However, the role of ricolinostat (ACY-1215, HDAC6 inhibitor) in the dexamethasone (Dex)-induced prolif...
Autores principales: | Wang, Na, Wang, Hua, Chen, Jianming, Wang, Fubin, Wang, Shuaiyi, Zhou, Qiang, Ying, Jichong, Huang, Shanzhao, Wang, Pu, Yuan, Fangfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411391/ https://www.ncbi.nlm.nih.gov/pubmed/32705192 http://dx.doi.org/10.3892/mmr.2020.11319 |
Ejemplares similares
-
HDAC6 inhibitor ACY1215 inhibits the activation of NLRP3 inflammasome in acute liver failure by regulating the ATM/F‐actin signalling pathway
por: Chen, Qian, et al.
Publicado: (2021) -
Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice
por: Zhang, Wen-bin, et al.
Publicado: (2019) -
Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases
por: Li, Jianglei, et al.
Publicado: (2022) -
Corrigendum: Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases
por: Li, Jianglei, et al.
Publicado: (2022) -
miR-365 Ameliorates Dexamethasone-Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4
por: Xu, Daohua, et al.
Publicado: (2017)